Envista Holdings Corporation (NVST)Healthcare | Medical Instruments & Supplies | Brea, United States | NYSE
27.84 USD
+0.90
(3.341%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 28.00 +0.16 (0.575%) ⇧ (April 17, 2026, 7:57 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:41 p.m. EDT
NVST is a classic 'contrarian turnaround' candidate. Fundamentals are showing massive improvement with +31% earnings growth and margin expansion, yet valuation (99x trailing PE) is distorted by the historical lack of earnings. The long-term story (Rating 2) is a 'sit and wait' for the stock to re-price to forward earnings; entering now requires faith that the revenue growth is sustainable. Short-term (Rating 3), the 52-week high energy has faded slightly, but the absence of put buying and massive gain exposure at $30 suggests the broader institutional narrative remains bullish on the compounder thesis. Avoid for short-term momentum plays unless a break above $28.50 occurs; it is a patience trade, not a quick flip. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.103190 |
| AutoARIMA | 0.105715 |
| AutoETS | 0.105759 |
| AutoTheta | 0.107562 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.524 |
| Excess Kurtosis | -0.82 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 51.434 |
| Revenue per Share | 16.188 |
| Market Cap | 4,562,290,688 |
| Trailing P/E | 99.43 |
| Forward P/E | 17.86 |
| Beta | 0.99 |
| Profit Margins | 1.73% |
| Website | https://envistaco.com |
As of April 18, 2026, 10:41 p.m. EDT: Options flow shows a distinct bullish skew. Call activity is heavy at $30 strikes (3% away, +7.8% volume spike) across all expirations, establishing a strong support floor. However, put activity remains negligible (near zero volume/OI), indicating a lack of hedging or bearish positioning despite the short-term downtrend. The lack of put buying suggests traders view the 52-week low ($14.72) as unlikely support. Implied volatility is compressed (0.0-0.74 range), suggesting pricing was based on low-movement expectations prior to recent news flow.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.872226 |
| Address1 | Building E |
| Address2 | 200 South Kraemer Boulevard |
| All Time High | 52.03 |
| All Time Low | 10.08 |
| Ask | 28.75 |
| Ask Size | 400 |
| Audit Risk | 6 |
| Average Analyst Rating | 2.1 - Buy |
| Average Daily Volume10 Day | 1,911,310 |
| Average Daily Volume3 Month | 2,798,101 |
| Average Volume | 2,798,101 |
| Average Volume10Days | 1,911,310 |
| Beta | 0.985 |
| Bid | 26.86 |
| Bid Size | 600 |
| Board Risk | 1 |
| Book Value | 18.964 |
| City | Brea |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 27.84 |
| Current Ratio | 2.377 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 28.28 |
| Day Low | 27.343 |
| Debt To Equity | 51.434 |
| Display Name | Envista |
| Earnings Call Timestamp End | 1,778,101,200 |
| Earnings Call Timestamp Start | 1,778,101,200 |
| Earnings Growth | 31.461 |
| Earnings Quarterly Growth | 26.417 |
| Earnings Timestamp | 1,778,097,600 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | 361,500,000 |
| Ebitda Margins | 0.13293 |
| Enterprise To Ebitda | 13.688 |
| Enterprise To Revenue | 1.82 |
| Enterprise Value | 4,948,291,072 |
| Eps Current Year | 1.41083 |
| Eps Forward | 1.55886 |
| Eps Trailing Twelve Months | 0.28 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 714 817 5450 |
| Fifty Day Average | 27.1216 |
| Fifty Day Average Change | 0.71840096 |
| Fifty Day Average Change Percent | 0.02648815 |
| Fifty Two Week Change Percent | 87.2226 |
| Fifty Two Week High | 30.42 |
| Fifty Two Week High Change | -2.58 |
| Fifty Two Week High Change Percent | -0.08481262 |
| Fifty Two Week Low | 14.72 |
| Fifty Two Week Low Change | 13.12 |
| Fifty Two Week Low Change Percent | 0.8913043 |
| Fifty Two Week Range | 14.72 - 30.42 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,568,813,400,000 |
| Float Shares | 163,172,372 |
| Forward Eps | 1.55886 |
| Forward P E | 17.859205 |
| Free Cashflow | 232,762,496 |
| Full Exchange Name | NYSE |
| Full Time Employees | 12,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.55021 |
| Gross Profits | 1,496,300,032 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00463 |
| Held Percent Institutions | 1.14298 |
| Implied Shares Outstanding | 163,875,398 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California. |
| Long Name | Envista Holdings Corporation |
| Market | us_market |
| Market Cap | 4,562,290,688 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_629627778 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 47,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,537,386,864 |
| Number Of Analyst Opinions | 13 |
| Open | 27.45 |
| Operating Cashflow | 275,700,000 |
| Operating Margins | 0.10738 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 714 817 7000 |
| Post Market Change | 0.15999985 |
| Post Market Change Percent | 0.5747121 |
| Post Market Price | 28.0 |
| Post Market Time | 1,776,470,221 |
| Previous Close | 26.94 |
| Price Eps Current Year | 19.733065 |
| Price Hint | 2 |
| Price To Book | 1.4680446 |
| Price To Sales Trailing12 Months | 1.6776211 |
| Profit Margins | 0.017280001 |
| Quick Ratio | 1.925 |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.13333 |
| Region | US |
| Regular Market Change | 0.9 |
| Regular Market Change Percent | 3.34076 |
| Regular Market Day High | 28.28 |
| Regular Market Day Low | 27.343 |
| Regular Market Day Range | 27.343 - 28.28 |
| Regular Market Open | 27.45 |
| Regular Market Previous Close | 26.94 |
| Regular Market Price | 27.84 |
| Regular Market Time | 1,776,456,003 |
| Regular Market Volume | 1,577,839 |
| Return On Assets | 0.02782 |
| Return On Equity | 0.01556 |
| Revenue Growth | 0.15 |
| Revenue Per Share | 16.188 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 162,980,850 |
| Shares Percent Shares Out | 0.059499998 |
| Shares Short | 9,691,732 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,515,894 |
| Short Name | Envista Holdings Corporation |
| Short Percent Of Float | 0.066599995 |
| Short Ratio | 3.99 |
| Source Interval | 15 |
| State | CA |
| Symbol | NVST |
| Target High Price | 35.0 |
| Target Low Price | 19.0 |
| Target Mean Price | 28.53846 |
| Target Median Price | 29.0 |
| Total Cash | 1,211,699,968 |
| Total Cash Per Share | 7.394 |
| Total Debt | 1,597,699,968 |
| Total Revenue | 2,719,500,032 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.28 |
| Trailing P E | 99.42857 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 22.54275 |
| Two Hundred Day Average Change | 5.2972507 |
| Two Hundred Day Average Change Percent | 0.2349869 |
| Type Disp | Equity |
| Volume | 1,577,839 |
| Website | https://envistaco.com |
| Zip | 92,821-6208 |